Dexcom Schedules First Quarter 2024 Earnings Release and Conference Call for April 25, 2024 at 4:30 p.m. Eastern Time
02 4월 2024 - 9:30PM
Business Wire
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to
release its first quarter 2024 financial results after market close
on Thursday, April 25, 2024. Management will hold a conference call
to review the company's first quarter 2024 performance starting at
4:30 p.m. (Eastern Time) on the same day. The conference call will
be concurrently webcast. The link to the webcast will be available
on the Dexcom investor relations website at investors.dexcom.com
and will be archived there for future reference.
To listen to the conference call, please dial (877) 344-3040
(US/Canada) or (646) 475-1647 (International) and use the
confirmation ID "9430114" approximately five minutes prior to the
start time.
About DexCom, Inc.
DexCom, Inc. empowers people to take control of health through
innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, California, and with operations across
Europe and select parts of Asia/Oceania, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
users, caregivers, and providers, Dexcom simplifies and improves
diabetes management around the world. For more information about
Dexcom CGM, visit www.dexcom.com.
Category: IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240402554023/en/
Sean Christensen Vice President – Finance and Investor Relations
investor-relations@dexcom.com (858) 200-0200
DexCom (NASDAQ:DXCM)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
DexCom (NASDAQ:DXCM)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
